These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3258505)
1. Renal impairment in relation to non-steroidal anti-inflammatory drugs. Dixon JS; Bojar R; Bird HA Ann Rheum Dis; 1988 Mar; 47(3):260. PubMed ID: 3258505 [No Abstract] [Full Text] [Related]
2. Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency. Brooks PM; McCredie M; Prowse M; Podgorski M; Forrest M; Munro I; Boutagy J; Pei-Ling L Pharmatherapeutica; 1986; 4(10):665-72. PubMed ID: 3602018 [TBL] [Abstract][Full Text] [Related]
3. [Tenoxicam and renal function. Short-term and long-term prospective studies]. Giovannoni JL; Ott H; de Torrenté A Schweiz Med Wochenschr; 1990 May; 120(21):793-7. PubMed ID: 2349462 [TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis caused by tenoxicam. Sungur C; Ates B; Akbas O Ann Pharmacother; 1994 Nov; 28(11):1309. PubMed ID: 7849359 [No Abstract] [Full Text] [Related]
5. Tenoxicam and renal function. Heintz RC Drug Saf; 1995 Feb; 12(2):110-9. PubMed ID: 7766336 [TBL] [Abstract][Full Text] [Related]
7. Gastric inflammatory polyposis after long-term intermittent use of nonsteroidal anti-inflammatory drugs and histamine2-receptor antagonists. Hizawa K; Takeya T; Yao T; Yamamoto H; Aomi H; Nakahara T; Matsumoto T; Iida M Endoscopy; 2005 Jul; 37(7):685. PubMed ID: 16010622 [No Abstract] [Full Text] [Related]
8. [Stevens-Johnson syndrome caused by isoxicam]. Capizzi R; Cacciaguerra MG; Guerriero G; Tulli A G Ital Dermatol Venereol; 1986; 121(6):461-2. PubMed ID: 3557542 [No Abstract] [Full Text] [Related]
9. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis. Gentiletti AA Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116 [No Abstract] [Full Text] [Related]
12. [Alopecia secondary to tenoxicam. An undescribed adverse effect?]. Aroca García MD; Luna Rodríguez C; Gallego Navarro MA; Ortiz de Solar E Aten Primaria; 1997; 20(3):157. PubMed ID: 9303679 [No Abstract] [Full Text] [Related]
18. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis. Astorga G Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111 [No Abstract] [Full Text] [Related]
19. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis. Havranek H Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099 [No Abstract] [Full Text] [Related]
20. [Tenoxicam-induced agranulocytosis, with good response to colony stimulating factor (G-CSF)]. Sánchez Sevillano A; Blázquez Encinar JC; Femenia Pérez M; Mora Rufete MA An Med Interna; 1993 Oct; 10(10):519-20. PubMed ID: 7511003 [No Abstract] [Full Text] [Related] [Next] [New Search]